Merck KGaA (XSWX:MER)
CHF 223 0 (0%) Market Cap: 77.56 Bil Enterprise Value: 86.30 Bil PE Ratio: 24.98 PB Ratio: 2.30 GF Score: 90/100

Q1 2024 Merck KGaA Earnings Call Transcript

May 15, 2024 / 12:00PM GMT
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on First Quarter 2024. (Operator Instructions) I am now handing over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest

Thank you very much, Heidi, and a very warm welcome to this Merck Q1 2024 Results Call. My name is Constantin Fest, I'm Head of Investor Relations here, and I'm delighted to be joined by Belen Garijo, Group CEO; as well as Helene von Roeder, Group CFO. For the Q&A part of this call, we will also be joined by Matthias Heinzel, CEO of Life Science; by Peter Guenter, CEO of Healthcare; as well as Kai Beckmann, CEO of Electronics.

In the first couple of minutes of this call, we'd like to run you through the key slides of this presentation, which will then be followed by Q&A.

With this, I'd like to hand over now to Belen to start. Over to you, Belen.

Belen Garijo Lopez
Merck KGaA - Chair of Executive Board & CEO

Thanks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot